These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11431375)

  • 1. Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies.
    Ikezoe T; Miller CW; Kawano S; Heaney A; Williamson EA; Hisatake J; Green E; Hofmann W; Taguchi H; Koeffler HP
    Cancer Res; 2001 Jul; 61(13):5307-10. PubMed ID: 11431375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
    Begum NM; Nakashiro K; Kawamata H; Uchida D; Shintani S; Ikawa Y; Sato M; Hamakawa H
    Int J Oncol; 2002 Mar; 20(3):599-605. PubMed ID: 11836575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells.
    Han SW; Greene ME; Pitts J; Wada RK; Sidell N
    Clin Cancer Res; 2001 Jan; 7(1):98-104. PubMed ID: 11205925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene.
    Tomita S; Kawamata H; Imura J; Omotehara F; Ueda Y; Fujimori T
    Int J Mol Med; 2002 May; 9(5):485-8. PubMed ID: 11956653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
    Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice.
    Ollero M; Junaidi O; Zaman MM; Tzameli I; Ferrando AA; Andersson C; Blanco PG; Bialecki E; Freedman SD
    J Cell Physiol; 2004 Aug; 200(2):235-44. PubMed ID: 15174093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C; Liu H; Posch MG; Waechter M; Facklam M; Fenner MH; Ruthardt M; Possinger K; Phillip Koeffler H; Elstner E
    Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
    Xu Y; Iyengar S; Roberts RL; Shappell SB; Peehl DM
    J Cell Physiol; 2003 Jul; 196(1):131-43. PubMed ID: 12767049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and functional role of peroxisome proliferator-activated receptor-gamma in ovarian folliculogenesis in the sheep.
    Froment P; Fabre S; Dupont J; Pisselet C; Chesneau D; Staels B; Monget P
    Biol Reprod; 2003 Nov; 69(5):1665-74. PubMed ID: 12890736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The increased expression of peroxisome proliferator-activated receptor-gamma1 in human breast cancer is mediated by selective promoter usage.
    Wang X; Southard RC; Kilgore MW
    Cancer Res; 2004 Aug; 64(16):5592-6. PubMed ID: 15313896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer.
    Inoue K; Kawahito Y; Tsubouchi Y; Yamada R; Kohno M; Hosokawa Y; Katoh D; Bishop-Bailey D; Hla T; Sano H
    Anticancer Res; 2001; 21(4A):2471-6. PubMed ID: 11724309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
    Chen A; Xu J
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma and cancers.
    Koeffler HP
    Clin Cancer Res; 2003 Jan; 9(1):1-9. PubMed ID: 12538445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-inhibitory effect of a novel synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, on ovarian carcinoma cell lines not dependent on peroxisome proliferator-activated receptor-gamma expression.
    Melichar B; Konopleva M; Hu W; Melicharova K; Andreeff M; Freedman RS
    Gynecol Oncol; 2004 Apr; 93(1):149-54. PubMed ID: 15047229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of peroxisome proliferator-activated receptor gamma does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin on human colorectal cancer cells.
    Hawcroft G; Gardner SH; Hull MA
    J Pharmacol Exp Ther; 2003 May; 305(2):632-7. PubMed ID: 12606626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases.
    Mukunyadzi P; Ai L; Portilla D; Barnes EL; Fan CY
    Mod Pathol; 2003 Dec; 16(12):1218-23. PubMed ID: 14681322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
    Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
    Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.